SIGA Technologies, Inc.

NASDAQ:SIGA

Drug Manufacturers - Specialty & Generic

Healthcare
$2.80 -0.36%

-$0.02 today

Market cap
$201.19M
Beta
0.85
P/E (TTM)
15.2
EPS (TTM)
$0.28
Dividend yield
13.97%
52W Low $4.10High $9.62

Volume 0.37M

Average 0.61M

SIGA Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

SIGA Technologies, Inc.NASDAQ: SIGA

Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026

Selling, general & admin growth accelerates

Q1 FY2026 selling, general & admin of $4.67T rose 82334154.6% year over year, ahead of the +20374087.6% change in trailing-twelve-month selling, general & admin. Over 3 fiscal years it compounded at -55.3% a year.

Context

  • Selling, general & admin amounted to 3.3% of revenue in FY2025, down 14.8 pp from a year earlier.
  • Selling, general & admin increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether selling, general & admin reaches the consensus estimate from 1 analysts of $8.82M (+182.0%) for the fiscal year ending Dec 2026, a step up from the -87.6% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$4.67T+36446706.2% QoQ
Last fiscal yearDec 2025
$3.13M-87.6% YoY
LTMMar 2026
$4.67T+20374087.6% YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+82334154.6%——
1 year-87.6%+182.0%+269.6 pp
3-year CAGR-55.3%——
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

USD · from the income statement

Latest · FY2025
3.13M USD
Year-over-year change
-87.6%
4-year CAGR
-35.5%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Selling, General & Admin vs competitors

How SIGA compares with its peers on the latest reported figures

  • Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +20374087.6% is the highest of 10, against a peer median of +1.1%.
  • Selling, general & admin amounts to 4982813.7% of revenue for SIGA, versus a peer median of 50.9%.
SIGA Competitors
Selling, General & Admin for SIGA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SIGASIGA Technologies, Inc.LTM Mar 2026$4.67T USD+20374087.6%-55.3%4982813.7%
ORGOOrganogenesis Holdings Inc.LTM Mar 2026$318.91M USD+8.2%+4.8%62.1%
SNDLSNDL Inc.LTM Mar 2026CA$210.35M CAD-3.8%+10.0%22.4%
EBSEmergent BioSolutions Inc.LTM Mar 2026$180.5M USD-32.3%-18.1%26.7%
ESPREsperion Therapeutics, Inc.LTM Mar 2026$165.91M USD+1.1%+15.0%39.7%
RIGLRigel Pharmaceuticals, Inc.LTM Mar 2026$118.84M USD+5.8%+1.0%39.6%
AQSTAquestive Therapeutics, Inc.LTM Mar 2026$71.75M USD+22.5%+14.7%142.7%
DRIODarioHealth Corp.LTM Mar 2026$34.47M USD-17.2%-8.8%162.7%
CTMXCytomX Therapeutics, Inc.LTM Mar 2026$31.1M USD-1.0%-11.4%87.5%
OLMAOlema Pharmaceuticals, Inc.LTM Mar 2026$25.39M USD+44.8%-5.3%—
Peer median (excluding SIGA) —+1.1%+1.0%50.9%

Competitors are the stored peer set for SIGA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue133.67M110.78M139.92M138.72M94.6M
Cost of Revenue16.6M10.43M17.83M31.29M29.7M
Gross Profit117.07M100.34M122.09M107.43M64.87M
Gross Margin87.6%90.6%87.3%77.4%68.6%
Research & Development9.94M22.53M16.43M12.31M6.53M
Selling, General & Admin18.03M35.12M22.04M25.14M3.13M
Operating Expenses27.98M57.64M38.47M37.45M41.17M
Depreciation & Amortization522.37K517.64K538.29K538.42K562.61K
EBITDA89.83M44.65M88.31M76.61M30.96M
EBITDA Margin67.2%40.3%63.1%55.2%32.7%
Operating Income89.09M42.7M83.62M69.98M23.7M
Operating Margin66.7%38.5%59.8%50.4%25.1%
Interest Income00006.68M
Interest Expense00000
Other Income / Expenses218.94K1.43M4.16M6.09M6.7M
Income Before Tax89.31M44.13M87.78M76.07M30.4M
Pre-Tax Margin66.8%39.8%62.7%54.8%32.1%
Income Tax Expense19.86M10.23M19.71M16.86M7.1M
Net Income69.45M33.9M68.07M59.21M23.3M
Net Margin52.0%30.6%48.6%42.7%24.6%
EPS (Basic)0.920.460.950.830.33
EPS (Diluted)0.910.460.950.830.33
Weighted Avg Shares75.32M72.93M71.36M71.25M71.6M
Weighted Avg Shares (Diluted)76.4M73.55M71.68M71.77M71.6M

SIGA Technologies, Inc.

NASDAQ:SIGA

Intrinsic Alpha fair value

Locked

Current Price

$2.80

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.